Cell Signaling Technology

Aurora Antibody Sampler Kit

#3875 · $427

100
Citing papers
12.4k
Combined citations
Supplier page Find this product

Research areas

MicroRNA in disease regulation11Cancer-related molecular mechanisms research11RNA modifications and cancer6PI3K/AKT/mTOR signaling in cancer6Cancer Mechanisms and Therapy4Circular RNAs in diseases4Cytokine Signaling Pathways and Interactions4CAR-T cell therapy research4

Papers citing this product

1
Exosomes maintain cellular homeostasis by excreting harmful DNA from cells
Nature Communications·2017·748 cit.·DOI
2
Nrf2 and Keap1 Abnormalities in Non–Small Cell Lung Carcinoma and Association with Clinicopathologic Features
Clinical Cancer Research·2010·422 cit.·DOI
3
<i>Arabidopsis</i>RECEPTOR-LIKE PROTEIN30 and Receptor-Like Kinase SUPPRESSOR OF BIR1-1/EVERSHED Mediate Innate Immunity to Necrotrophic Fungi  
The Plant Cell·2013·290 cit.·DOI
4
Hereditary mixed polyposis syndrome is caused by a 40-kb upstream duplication that leads to increased and ectopic expression of the BMP antagonist GREM1
Nature Genetics·2012·281 cit.·DOI
5
Human Endometrial Exosomes Contain Hormone-Specific Cargo Modulating Trophoblast Adhesive Capacity: Insights into Endometrial-Embryo Interactions1
Biology of Reproduction·2016·279 cit.·DOI
6
T-cell Immunoglobulin and ITIM Domain (TIGIT) Receptor/Poliovirus Receptor (PVR) Ligand Engagement Suppresses Interferon-γ Production of Natural Killer Cells via β-Arrestin 2-mediated Negative Signaling
Journal of Biological Chemistry·2014·249 cit.·DOI
7
Pro-oxidative activities and dose–response relationship of (−)-epigallocatechin-3-gallate in the inhibition of lung cancer cell growth: a comparative study in vivo and in vitro
Carcinogenesis·2010·237 cit.·DOI
8
Ubiquilin functions in autophagy and is degraded by chaperone-mediated autophagy
Human Molecular Genetics·2010·225 cit.·DOI
9
Antagonistic antibody prevents toll-like receptor 2–driven lethal shock-like syndromes
Journal of Clinical Investigation·2004·214 cit.·DOI
10
Acquired RAS or EGFR mutations and duration of response to EGFR blockade in colorectal cancer
Nature Communications·2016·211 cit.·DOI